Cincera Therapeutics Overview

  • Founded
  • 2018
Founded
  • Status
  • Private
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $5.56M
Latest Deal Amount
  • Investors
  • 1

Cincera Therapeutics General Information

Description

Developer of inflammatory and fibrotic illness drug intended to cure metabolic diseases. The company's drug treats difficult-to-treat inflammatory and fibrotic conditions associated with obesity, it also has applicability in many other disease areas including cancer, and liver problems, enabling doctors to cure patients effectively.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
  • Melbourne, Victoria
  • Australia
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cincera Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 19-Feb-2018 $5.56M 00.000 Completed Startup
To view Cincera Therapeutics’s complete valuation and funding history, request access »

Cincera Therapeutics Executive Team (3)

Name Title Board Seat Contact Info
Bernard Flynn Co-Founder, Chief Executive Officer & Research Director
Stuart Pitson Co-Founder & Chief Scientific Officer
Michael Bettess Ph.D Executive Director & Board Member
To view Cincera Therapeutics’s complete executive team members history, request access »

Cincera Therapeutics Board Members (4)

Name Representing Role Since
Ben Atcliffe Ph.D Cincera Therapeutics Board Member 000 0000
Katherine Nielsen Cincera Therapeutics Board Member 000 0000
Melissa McBurnie Ph.D Self Chairman 000 0000
Michael Bettess Ph.D Self Executive Director & Board Member 000 0000
To view Cincera Therapeutics’s complete board members history, request access »

Cincera Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Brandon Capital Partners Venture Capital Minority 000 0000 000000 0
To view Cincera Therapeutics’s complete investors history, request access »